Fig. 5 Post-PKS steps of the gilvocarcin biosynthetic pathway: non-isolable, proposed intermediates are shown in brackets, and shunt products in blue. The pathway has only three isolable intermediates, homo-prejadomycin, vinyl-dehydrorabelomycin and pregilvocarcin V. 